Volume 9, Number 12—December 2003
Dispatch
Noninvasive Method for Monitoring Pneumocystis carinii Pneumonia
Table 2
Groupsb | No. points | Spearman r | 95% Confidence interval | p value | Significant |
---|---|---|---|---|---|
LH Pc DNA vs. post-OS Pc DNA |
22 |
0.5576 |
0.1648 to 0.7978 |
0.0070 |
Yes |
LH Pc DNA vs. Pc nuclei |
22 |
0.9035 |
0.7731 to 0.9606 |
<0.0001 |
Yes |
Post-OS Pc DNA vs. Pc Nuclei |
22 |
0.4636 |
0.0388 to 0.7465 |
0.0298 |
Yes |
Pre-OS Pc DNA vs. post-OS Pc DNA |
21* |
0.3707 |
-0.0863 to 0.6988 |
0.0980 |
No |
Pre-OS Pc DNA vs Pc Nuclei |
21 |
0.4123 |
-0.0374 to 0.7232 |
0.0633 |
No |
Pre-OS Pc DNA vs. LH Pc DNA | 21 | 0.2939 | -0.1712 to 0.6519 | 0.1960 | No |
a21 data points were included in these analyses because 2 rats from the 10-wk group died and 1 preimmunosuppression oral swab sample in the 7-wk group was lost in processing.
bPre-OS Pc DNA, P. carinii –specific DNA from oral swabs taken prior to immunosuppression; post-OS Pc DNA, P. carinii–specific DNA from oral swabs taken at the time of euthanasia; LH Pc DNA, P. carinii–specific DNA from lung homogenates of rats at the 3 different time points; log Pc Nuclei, P. carinii organism number assessed by microscopic enumeration.
Page created: February 09, 2011
Page updated: February 09, 2011
Page reviewed: February 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.